IDEXX Laboratories' oncology panel and share buybacks boost outlook. Read why IDXX stock is upgraded to buy with growth ...

Registration will open on Wednesday, March 12 for both AHN and non-AHN patients. Those interested in attending must make an ...

Ann Platte of Green Bay has taken the leap to shave her head the last 10 years. The event has hit much closer to home for the ...

The American Cancer Society recommends people with an average risk of colorectal cancer start regular screening at age 45.

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The ...

The researchers reviewed data on symptom severity and COVID-19 vaccination status. Significantly more cancer survivors had ...

This review discusses the current state of multicancer early detection tests, the role of machine learning in their ...

AstraZeneca has entered the “off-the-shelf” cell therapy space, penning a $1 billion deal to acquire EsoBiotec and its lentiviral vector platform. The deal will see AstraZeneca scoop up all ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...

A Glasgow-based charity has received a £500 donation from a drug, alcohol, and DNA testing laboratory. Beatson Cancer Charity ...

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...

An advocacy group for survivors of clergy sexual abuse is demanding action from the Catholic Diocese of Peoria Bishop Louis ...